ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

Medical University of Vienna at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Medical University of Vienna takes part in 25 sessions at ESMO 2026 in Madrid. Its program spans personalized treatment and diagnostic approaches across brain, breast and other cancers. It explores testing glioblastoma cells outside the body to identify targeted therapies, alongside imaging approaches for detecting cancer.

OrganizationESMO 2026 Attendance
University & institute
Public medical university in Vienna, Austria, whose clinical departments are based at Vienna General Hospital.
Poster
Fri Oct 23
13:00–15:00
Current practice considerations for brain metastases in gastroesophageal cancer patients: An international EORTC survey
ePoster session 4
Gastrointestinal cancersSarcoma, CNS, head & neck and rare cancers
Poster
Fri Oct 23
13:00–15:00
Longitudinal biomarker trajectories of pre-cachexia in patients with solid cancer
ePoster session 20
Biomarkers & precision oncology
Poster
Fri Oct 23
13:00–15:00
Personalized targeted glioblastoma therapies by ex vivo drug screening: Advanced brain Tumor TheRApy Clinical Trial (ATTRACT)
ePoster session 4
Sarcoma, CNS, head & neck and rare cancersBiomarkers & precision oncology
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Talk
Fri Oct 23
13:30–13:50
How to select the optimal adjuvant therapy
Update on the mangement of endometrial cancer in the era of molecular classification
Gynaecological cancers
Chair
Fri Oct 23
13:30–15:00
Update on the mangement of endometrial cancer in the era of molecular classification
with European Institute of Oncology (IEO)
Gynaecological cancers
Abstract
Fri Oct 23
13:35–13:40
Abstract
Fri Oct 23
14:37–14:42
703RO - Inflammatory and epigenetic signatures in progressive brain metastases after cranial radiotherapy
Rapid oral: CNS tumours
Sarcoma, CNS, head & neck and rare cancers
Keynote
Fri Oct 23
15:15–15:20
Introduction
Keynote lecture 1
Sarcoma, CNS, head & neck and rare cancers
Chair
Fri Oct 23
15:15–15:45
Keynote lecture 1
Sarcoma, CNS, head & neck and rare cancers
Poster
Fri Oct 23
15:15–16:00
SARS-CoV-2 mRNA and immune-related adverse events in patients with head and neck squamous cell carcinoma and lung cancer
Friday Poster Display session 2
Lung & thoracic cancersSarcoma, CNS, head & neck and rare cancers
Poster
Fri Oct 23
15:15–16:00
Use of genome-wide non-small cell lung cancer DNA methylation profiles to predict immune checkpoint inhibitor response
Friday Poster Display session 4
Lung & thoracic cancersBiomarkers & precision oncology
Poster
Fri Oct 23
15:15–16:00
Talk
Sat Oct 24
08:50–09:10
Immune niche development and metastases
Metastases: Understanding and targeting cancer spread
Biomarkers & precision oncology
Chair
Sat Oct 24
10:30–11:15
YO Brunch 1
with Hacettepe University
Poster
Sat Oct 24
12:00–12:45
70-Gene signature provides prognostic value beyond Ki67 in HR+HER2– early breast cancer (EBC)
Saturday Poster Display session 1
Breast cancerBiomarkers & precision oncology
Poster
Sat Oct 24
12:00–12:45
Poster
Sat Oct 24
12:00–12:45
Poster
Sat Oct 24
12:00–12:45
Development and validation of a novel survival-driven risk score for cancer-associated cachexia
Saturday Poster Display session 6
Nursing & supportive care
Poster
Sat Oct 24
12:00–12:45
Neurological symptoms independently associate with overall survival in patients with melanoma brain metastases
Saturday Poster Display session 3
Sarcoma, CNS, head & neck and rare cancersMelanoma & skin cancers
Poster
Sat Oct 24
12:00–12:45
Satellite
Sat Oct 24
13:00–13:10
Overview GI Cancers: Translating Innovation into Practice and Better Patient Care
Servier - GI Oncology in Motion : Real-World Cases and Patient Centric Care
Gastrointestinal cancersBiomarkers & precision oncology
Satellite
Sat Oct 24
13:00–14:30
Servier - GI Oncology in Motion : Real-World Cases and Patient Centric Care
with Hospital Universitario Fundación Jiménez Díaz
Gastrointestinal cancersBiomarkers & precision oncology
Chair
Sun Oct 25
09:00–10:00
YO Clinical case discussions
with University Hospital Essen
Abstract
Sun Oct 25
09:42–09:52
Invited Discussant 3588O and 3592O
Proffered paper 2: Genitourinary tumours, renal and urothelial
Genitourinary cancers
Abstract
Sun Oct 25
10:15–10:25
Chair
Sun Oct 25
10:15–11:45
Proffered paper: CNS tumours
with IRCCS Institute of Neurological Sciences of Bologna
Sarcoma, CNS, head & neck and rare cancers
Chair
Sun Oct 25
10:15–11:45
Tumour systemic immunity
with Institute of Oncology Research (IOR)
Chair
Sun Oct 25
14:45–16:15
Key challenges in managing patients with metastatic breast cancer
with Hospital Universitario 12 de Octubre
Breast cancer
Chair
Mon Oct 26
14:45–16:00
Modern management of leptomeningeal metastases
with Maastricht UMC+
Sarcoma, CNS, head & neck and rare cancers
Chair
Mon Oct 26
14:45–16:15
Rapid oral: Prevention, early detection and intervention
with Netherlands Cancer Institute, MD Anderson Cancer Center
Talk
Mon Oct 26
15:10–15:30
Systemic therapies for leptomenigeal disease
Modern management of leptomeningeal metastases
Sarcoma, CNS, head & neck and rare cancers
Abstract
Mon Oct 26
15:22–15:34
Invited Discussant 3884RO, 1150RO and 1151RO
Rapid oral: Prevention, early detection and intervention

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Medical University of Vienna

Tell us what you sell and we’ll find the people at Medical University of Vienna most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction